Showing results (61-70 of 463) with videos related to
Sort By:
Pageof 47
Journal of Medicinal Chemistry|February 14, 2025
Dissecting Structural Requirements of Leucinostatin A Derivatives for Antiprotozoal Activity and Mammalian ToxicityLukas Rimle, Dimanthi Pliatsika, Noëlle Arnold, et al.Blood|August 14, 2010
FLT3 as a therapeutic target in AML: still challenging after all these yearsThomas Kindler, Daniel B Lipka, Thomas FischerThe Journal of Organic Chemistry|October 24, 2001
Trends in Inversion Barriers of Group 15 Compounds. 3. Are Fluorinated Pyridone Derivatives Planar or Nonplanar?Patricia A. Hunt, Thomas Fischer, Peter SchwerdtfegerEuropean Geriatric Medicine|April 17, 2020
Pain and delirium: mechanisms, assessment, and managementElizabeth L Sampson, Emily West, Thomas FischerPediatric Emergency Care|September 17, 2009
Observation option for acute otitis media in the emergency departmentThomas Fischer, Adam J Singer, Stuart ChaleJournal of Neuroinflammation|December 16, 2022
Bovine neutrophil chemotaxis to Listeria monocytogenes in neurolisteriosis depends on microglia-released rather than bacterial factorsStefano Bagatella, Neda Haghayegh Jahromi, Camille Monney, et al.Academic Radiology|March 25, 2017
Diagnostic Performance of Automated Breast Volume Scanning (ABVS) Compared to Handheld Ultrasonography With Breast MRI as the Gold StandardConstanze Schmachtenberg, Thomas Fischer, Bernd Hamm, et al.Journal of Forensic and Legal Medicine|July 2, 2021
Effects of antibiotics ceftriaxone and levofloxacin on the growth of Calliphora vomitoria L. (Diptera: Calliphoridae) and effects on the determination of the post-mortem intervalDaniel Preußer, Udo Bröring, Thomas Fischer, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 6, 2014
Quantitative tool to evaluate the somatic burden due to chemotherapy-induced adverse events: the somatic burden scoreMichael Koehler, Thomas Fischer, Siegfried Kropf, et al.Annals of Hematology|January 27, 2018
Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutationAlissa Marhäll, Florian Heidel, Thomas Fischer, et al.Pageof 47